Population Pharmacokinetic Analysis of Tepotinib, an Oral MET Kinase Inhibitor, Including Data From the VISION Study

Cancer Chemother Pharmacol. 2022 May;89(5):655-669.

Xiong W, Papasouliotis O, Jonsson EN, Strotmann R, Girard P